Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With Sulphonylurea

NCT02471404 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

939

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Inadequate Glycaemic Control

Interventions

DRUG: Dapagliflozin
DRUG: Saxagliptin
DRUG: Glimepiride
DRUG: Placebo for dapagliflozin
DRUG: Placebo for saxagliptin
DRUG: Placebo for glimepiride

Sponsor

AstraZeneca